Neuland Laboratories is trading 2.52% upper at Rs 11,969.00 as compared to its last closing price. Neuland Laboratories has been trading in the price range of 12,479.05 & 11,711.65. Neuland Laboratories has given -14.70% in this year & -1.45% in the last 5 days. Neuland Laboratories has TTM P/E ratio 59.54 as compared to the sector P/E of 22.97.There are 2 analysts who have initiated coverage on Neuland Laboratories. There are - analysts who have given it a strong buy rating & - analysts have given it a buy rating. - analysts have given the stock a sell rating.The company posted a net profit of 27.81 Crores in its last quarter.Listed peers of Neuland Laboratories include Pfizer (-0.83%), Astrazeneca Pharma India (1.75%), Neuland Laboratories (2.52%).The Mutual Fund holding in Neuland Laboratories was at 7.43% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Neuland Laboratories was at 22.12% in 31 Mar 2025. The FII holding has decreased from the last quarter.
Updated on Jul 09, 2025, 11:16 PM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Pfizer | Bullish | 5,674.00 | -0.83 | 25,957.26 | 41.47 | 6.27 | 0.61 | 1.60 |
Astrazeneca Pharma India | Bullish | 9,297.00 | 1.75 | 23,234.11 | 121.55 | 29.57 | 0.26 | 3.82 |
Neuland Laboratories | Bullish | 11,969.00 | 2.52 | 15,322.56 | 73.84 | 9.82 | 0.10 | 7.17 |
Unichem Laboratories | Neutral | 602.65 | 0.59 | 4,233.11 | 30.01 | 1.68 | - | 3.51 |
Jagsonpal Pharmaceuticals | Bullish | 231.15 | 0.92 | 1,537.76 | 38.93 | 6.36 | 0.87 | 3.18 |
Meeting Date | Purpose |
---|---|
2025-05-15 | Audited Results & Final Dividend |
2025-02-10 | Quarterly Results |
2024-11-06 | Quarterly Results |
2024-08-01 | Quarterly Results |
2024-05-10 | Audited Results & Final Dividend |
Neuland Laboratories is trading at 11969.00 as on Wed Jul 09 2025 09:59:47. This is 2.52% upper as compared to its previous closing price of 11674.45.
The market capitalization of Neuland Laboratories is 15322.56 Cr as on Wed Jul 09 2025 09:59:47.
The 52 wk high for Neuland Laboratories is 18089.55 whereas the 52 wk low is 7575.00
Neuland Laboratories can be analyzed on the following key metrics -
Neuland Laboratories reported a net profit of 260.11 Cr in 2025.
The Mutual Fund Shareholding was 7.43% at the end of 31 Mar 2025.